P-net uses a neural network architecture based on biological knowledge of hierarchical gene-pathway-process interactions to predict prostate cancer discovery from gene features, such as methylation and copy number [32]
The physiological importance of tRNA modifications is demonstrated by the finding that various human diseases are caused by their deficiency and/or misregulation 2,6,7,8
In late April 2022, Eli Lilly released preliminary results from the SURMOUNT-1 trial that included overweight and obese patients using tirzepatide who did not have diabetes
They only address the surface-level symptom, but not the root cause
Even then, sequencing matters
The limited response to ICBs in MM is mainly because of low mutation burden and limited immune cell infiltration compared to CM (176, 177)